Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

News > All

Total search results: 17217 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 171 172 173  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Domainex Ltd.. (2/25/20). "Press Release: Lunac Therapeutics Selects Domainex as Its Strategic Drug Discovery Partner". Cambridge & Leeds. 2020-02-25
Scipio Bioscience. (2/25/20). "Press Release: Scipio Bioscience Raises €6.0 M Series A Financing". Paris. 2020-02-25
FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". 2020-02-25
Bicycle Therapeutics plc. (2/25/20). "Press Release: Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle-based Immuno-oncology Therapies". Cambridge & Boston, MA. 2020-02-25
ProBioGen AG. (2/25/20). "Press Release: ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Schlieren. 2020-02-25
Sanofi S.A.. (2/24/20). "Press Release: Sanofi to Create New Industry Leading European Company to Provide Active Pharmaceutical Ingredients (API)". Paris. 2020-02-24
Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes. 2020-02-24
Adrenomed AG. (2/21/20). "Press Release: Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock". Hennigsdorf. 2020-02-21
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. 2020-02-21
CTC North GmbH & Co. KG. (2/20/20). "Press Release: Hope for Hepatitis B Patients. New Research Project to Cure Hepatitis B Patients under the European Horizon 2020 Programme". 2020-02-20
Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. 2020-02-20
Sophia Genetics S.A.. (2/20/20). "Press Release: Sophia Genetics’ Board of Directors Elects Troy Cox as New Chairman". Lausanne & Boston, MA. 2020-02-20
Tocagen Inc.. (2/19/20). "Press Release: Tocagen and Forte Biosciences Announce Merger. Transaction to Create Nasdaq-listed Company Focused on Advancing Forte's Late-Stage Clinical Program for Atopic Dermatitis". San Diego, CA & Torrance, CA. 2020-02-19
France Biotech. (2/19/20). "Press Release: Driven by Its Successful Debut, the Second Annual International HealthTech Innovation Days Will Take Place in Paris on June 22nd & 23rd". Paris. 2020-02-19
Merck KGaA. (2/19/20). "Press Release: Merck Divests Allergopharma to Dermapharm Holding SE". Darmstadt. 2020-02-19
BIA Separations d.o.o.. (2/19/20). "Press Release: BIA Separations and University of Zagreb Sign License Agreement to Commercialize Novel Elution Method for Virus and Viral Vector purification". Ajdovšcina & zagreb. 2020-02-19
Grifols S.A.. (2/18/20). "Press Release: Grifols and the Public Investment Fund of Saudi Arabia Taking Steps to Boost Plasma Medicines Self-supply in the Region". Barcelona. 2020-02-18
Cellectis S.A.. (2/18/20). "Press Release: Cellectis and Servier Expand Collaboration on UCART19 Products". New York, NY. 2020-02-18
Agilent Technologies Inc.. (2/18/20). "Press Release: Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results". Santa Clara, CA. 2020-02-18
Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. 2020-02-18
PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. 2020-02-17
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. 2020-02-17
Edinburgh Innovations. (2/17/20). "Press Release: Spinout Takes Aim at Treatments for Multiple Sclerosis". 2020-02-17
Scottish Enterprise. (2/17/20). "Press Release: Deputy First Minister Announces £9.5 Million to Compete in Global Precision Medicine Industry". 2020-02-17
OMass Therapeutics Ltd.. (2/17/20). "Press Release: OMass Therapeutics Announces £27.5 Million Extended Series A Financing". Oxford. 2020-02-17
TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. 2020-02-17
Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. 2020-02-17
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Pencil Biosciences, a Novel Gene Modulation Biotech". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Turbine". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Is Pleased to Announce an Investment in Neurofenix, an Innovative Digital Health Company". Cambridge. 2020-02-15
OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. 2020-02-14
Thermo Fisher Scientific Inc.. (2/13/20). "Press Release: Thermo Fisher Scientific Announces Collaboration to Develop Highly Sensitive Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring". San José, CA. 2020-02-13
Rentschler Biopharma SE. (2/13/20). "Press Release: Rentschler Biopharma Adds Senior Executive to Growing U.S. Team. Grace Kim Joins as Vice President Business Development – North America and APAC". Laupheim & Milford, MA. 2020-02-13
Domainex Ltd.. (2/13/20). "Press Release: Domainex Announces the Appointment of Tom Mander as Chief Executive Officer". Cambridge. 2020-02-13
Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. 2020-02-13
Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. 2020-02-12
Lexington Communications. (2/12/20). "Press Release: Leading Strategy and Public Affairs Consultancy Opens New Office in Cambridge". 2020-02-12
Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". 2020-02-12
OSE Immunotherapeutics S.A.. (2/12/20). "Press Release: OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico". Nantes. 2020-02-12
Aurora-TT S.r.l.. (2/12/20). "Press Release: Rottapharm Biotech and Italfarmaco Team Up with AurorA-TT to launch AurorA Science". Milano. 2020-02-12
CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA. 2020-02-12
Stilla Technologies S.A.S.. (2/11/20). "Press Release: Stilla Technologies Raises €20 Million ($22 Million) in Series B Round that Brings in New Investor, TUS-Holdings, alongside Existing Ones". Paris. 2020-02-11
ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. 2020-02-11
Bayer AG. (2/11/20). "Press Release: Bayer and Nuvisan Create New Research Unit in Berlin". Berlin. 2020-02-11
ProteoMedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür 2020-02-11
ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. 2020-02-10
Bayer AG. (2/10/20). "Press Release: Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies". Monheim & Paris. 2020-02-10
Nanoform Finland Ltd.. (2/10/20). "Press Release: Nanoform Establishes US Subsidiary". Helsinki. 2020-02-10
Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. 2020-02-10
Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. 2020-02-07
Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. 2020-02-06
Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. 2020-02-06
PentixaPharm GmbH. (2/6/20). "Press Release: PentixaPharm Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics". Würzburg. 2020-02-06
Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. 2020-02-06
Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. 2020-02-05
MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. 2020-02-05
MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. 2020-02-04
Inato. (2/4/20). "Press Release: Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures". Paris. 2020-02-04
BenchSci. (2/4/20). "Press Release: BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend". Toronto. 2020-02-04
Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. 2020-02-04
Gilead Sciences, Inc.. (2/4/20). "Press Release: Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results". Foster City, CA. 2020-02-04
Valneva S.E.. (2/3/20). "Press Release: Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed". Saint-Herblain. 2020-02-03
Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. 2020-02-03
Stalicla S.A.. (2/3/20). "Press Release: Swiss Biotech Stalicla Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A". Geneva. 2020-02-03
Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. 2020-02-03
Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. 2020-02-03
Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer". 2020-01-31
Business France. (1/31/20). "Press Release: France, Home to Laboratories. This year, 17 French Companies Present Their Expertise at Analytica". 2020-01-31
CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. 2020-01-31
GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva. 2020-01-31
Bayer AG. (1/31/20). "Press Release: Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic". Whippany, NJ. 2020-01-31
Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial". 2020-01-30
Gilead Sciences, Inc.. (1/30/20). "Press Release: Sandra Horning, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA. 2020-01-30
iTeos Therapeutics S.A.. (1/30/20). "Press Release: iTeos Therapeutics Awarded €15 Million in Non-Dilutive Funding by the Walloon Region". Gosselies & Cambridge, MA. 2020-01-30
Thermo Fisher Scientific Inc.. (1/30/20). "Press Release: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2019 Results". Waltham, MA. 2020-01-30
Mammoth Biosciences, Inc.. (1/30/20). "Press Release: Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products for Therapeutics and Diagnostics". South San Francisco, CA. 2020-01-30
Miltenyi Biotec B.V. & Co. KG. (1/30/20). "Press Release: Miltenyi Biotec Introduces World’s First Operator-free GMP-Compliant Cell Sorting System". Bergisch Gladbach. 2020-01-30
Coulter Partners. (1/28/20). "Press Release: Coulter Partners Secures Chief Financial Officer for Stilla Technologies". 2020-01-28
Gilead Sciences, Inc.. (1/28/20). "Press Release: European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy". Santa Monica, CA. 2020-01-28
Saga Diagnostics AB. (1/28/20). "Press Release: Saga Diagnostics Extends Its Collaboration with Servier to Use Ultrasensitive SAGAsafe Technology in Cancer Clinical Trials". Lund. 2020-01-28
Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. 2020-01-27
Biocartis Group N.V.. (1/27/20). "Press Release: Biocartis Announces Resignation of CFO". Mechelen. 2020-01-27
Merck KGaA. (1/27/20). "Press Release: Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland". Corsier-sur-Vevey. 2020-01-27
Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. 2020-01-24
Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris. 2020-01-24
Ervaxx Ltd.. (1/24/20). "Press Release: Ervaxx and Cardiff University Enter Collaboration to Develop novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens". London. 2020-01-24
C4Diagnostics S.A.S.. (1/24/20). "Press Release: C4Diagnostics Raises € 2.3 Million in Series A and Brings a US Investor to the Founding Round, to Accelerate the Deployment of Its Infectious Diseases’ Diagnostic Solutions". 2020-01-24
Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil. 2020-01-23
iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. 2020-01-23
Elypta AB. (1/23/20). "Press Release: Elypta Raises €6.1 Million in a Late Seed Round Led by Industrifonden". 2020-01-23
Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan". 2020-01-23
Oxford University Innovation. (1/23/20). "Press Release: Oxford Investment Opportunity Network and Oxford Angel Network Join Forces". 2020-01-23
Evotec SE. (1/23/20). "Press Release: Evotec and Indivumed Announce Second Joint Drug Discovery Programme". Hamburg. 2020-01-23
PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". 2020-01-23
Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. 2020-01-23
Heidelberg Pharma AG. (1/22/20). "Press Release: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder Dievini". Ladenburg. 2020-01-22
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". 2020-01-22
PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble. 2020-01-22
Coulter Partners. (1/22/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for OxStem". 2020-01-22
Bio-Techne Corporation. (1/21/20). "Press Release: Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies". Miami, FL. 2020-01-21
next pagenext page 1 2 3 ... 171 172 173  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top